European Union antitrust regulators have opened an in-depth investigation into Hutchison’s planned merger of its Italian mobile telecoms business with Vimpelcom’s, on concerns it could lead to higher prices for consumers.
“The Commission has concerns that the transaction could lead to higher prices, less choice and reduced innovation for mobile customers in Italy,” the European Commission said in a statement on Wednesday.
The companies said in a joint statement they had expected the deal to be investigated and would cooperate. “The combined business will have the scale, financial strength and a more efficient cost structure to offer Italian consumers and businesses a state-of-the-art network,” the statement said.
The proposed merger of Hutchison’s 3 Italia SpA and Vimpelcom’s WIND Telecommunicazioni will reduce the number of mobile network operators in Italy from four to three, a reduction which competition regulators think could lead to higher prices for users.
The transaction would also create the largest mobile operator by subscriber numbers in Italy.
The Commission has 90 days, until Aug. 10, to decide whether to approve the merger.
EU regulators have recently taken a harder line on mergers in the mobile telecoms market, casting doubt on claims that consolidation leads to higher investment in networks.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan